China Pharma Holdings, Inc. CPHI

Company Overview

China Pharma Holdings, Inc. is a specialty pharmaceutical company focused on the development, manufacturing, and marketing of pharmaceutical and nutraceutical products in the People’s Republic of China. The company operates primarily within the healthcare and pharmaceutical manufacturing industries, with an emphasis on prescription and over-the-counter medications targeting cardiovascular, cerebrovascular, infectious disease, digestive, and respiratory conditions. Its revenue is generated largely through sales of pharmaceutical products distributed to hospitals, clinics, and pharmaceutical distributors across China.

The company traces its origins to pharmaceutical operations in Hainan Province and later became publicly listed in the United States through a reverse merger transaction. Over time, China Pharma Holdings expanded its product portfolio to include formulations based on traditional Chinese medicine and modern pharmaceutical manufacturing techniques. The company has positioned itself as a smaller regional pharmaceutical producer focused on China’s domestic healthcare demand, leveraging manufacturing facilities and product approvals issued by Chinese regulatory authorities.